What Is ADMA Biologics Inc (ADMA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on ADMA Biologics Inc at its current price of $8.97. The composite intrinsic value is estimated at $7.91 (-11.8% average return), with 8 models flagging overvaluation risk. Model dispersion is worth noting: Markov DDM targets $15.33 (+70.9%), versus Dynamic NAV at $1.26 (-85.9%). This +156.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ADMA?
13 of 13 models are currently active for ADMA. Of these, 4 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates ADMA's intrinsic value at $7.97, implying -11.1% downside from the current price. See which stocks rank higher →
How Does ADMA Rank in Biotechnology?
Among 62 Biotechnology stocks, ADMA ranks #1 by Quality of Company score. CirclFi's QOC score of 10.0/10 evaluates 32 fundamental signals. A score of 10.0 places ADMA in the top tier.
See all Most Undervalued Biotechnology Stocks →
As a biotechnology enterprise, ADMA Biologics Inc operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating ADMA should weigh these sector-specific dynamics alongside our model-derived fair values.
Is ADMA a Value Trap?
CirclFi's Value Trap algorithm assigns ADMA a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for ADMA Biologics Inc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, ADMA Biologics Inc's fundamental quality profile registers 10.0/10. This exceptional score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +156.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ADMA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ADMA's 13 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad